NUZ neurizon therapeutics limited

FDA Application for Orphan Drug Designation , PAA, MPL, page-7

  1. 3,123 Posts.
    lightbulb Created with Sketch. 1191
    My timeline and corporate form are:
    • Q4, 2023: Funds received from the new oppies so remain compliant liquidity wise
    • Q1, 2024 final MND report report released
    • Q1, 2024 PAA receives100% cash takeover offer for all SOI
    • Heads of Agreement entered into which includes an exclusivity period, non refundable upfront payment and inclusion of all options.
    • Takeover recommended by the BoD
    • SHs agree to to takeover


    The big question would be the initial offer price. My guess ~45 cents (subsequently negotiated upwards?????)

    Some wayward thoughts only
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $83.69M
Open High Low Value Volume
16.5¢ 17.0¢ 16.5¢ $70.91K 420.5K

Buyers (Bids)

No. Vol. Price($)
4 104900 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 186536 2
View Market Depth
Last trade - 15.35pm 14/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.